TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 23 filers reported holding TALIS BIOMEDICAL CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,736,169 | +9.9% | 7,624,835 | 0.0% | 0.02% | 0.0% |
| Q4 2022 | $3,398,389 | -34.6% | 7,624,835 | 0.0% | 0.02% | -41.2% |
| Q3 2022 | $5,197,000 | -16.1% | 7,624,835 | 0.0% | 0.03% | -2.9% |
| Q2 2022 | $6,191,000 | -42.4% | 7,624,835 | 0.0% | 0.04% | -43.5% |
| Q1 2022 | $10,751,000 | -64.8% | 7,624,835 | 0.0% | 0.06% | -58.4% |
| Q4 2021 | $30,576,000 | -35.4% | 7,624,835 | +0.7% | 0.15% | -28.4% |
| Q3 2021 | $47,343,000 | -43.3% | 7,574,835 | 0.0% | 0.21% | -43.3% |
| Q2 2021 | $83,550,000 | -14.2% | 7,574,835 | 0.0% | 0.37% | -13.0% |
| Q1 2021 | $97,337,000 | – | 7,574,835 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 2,235,783 | $1,095,534 | 0.06% |
| Baker Brothers Advisors | 7,624,835 | $3,736,169 | 0.02% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 223,934 | $109,728 | 0.01% |
| ArrowMark Colorado Holdings LLC | 478,862 | $234,642 | 0.00% |
| WELLS FARGO & COMPANY/MN | 167 | $82 | 0.00% |
| NORTHERN TRUST CORP | 27,860 | $13,652 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 144,416 | $70,763 | 0.00% |
| STATE STREET CORP | 49,536 | $24,273 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 163,663 | $80 | 0.00% |